| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 85 |
| 1 | RITUXIMAB | 63 |
| 2 | CYCLOPHOSPHAMIDE | 47 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 47 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 47 |
| 5 | CARBOPLATIN | 41 |
| 6 | BEVACIZUMAB | 39 |
| 7 | CAPECITABINE | 37 |
| 8 | TACROLIMUS | 36 |
| 9 | DOXORUBICIN | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 2 | CALAMINE | 1 | 0.0023 |
| 3 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 1 | 0.0022 |
| 4 | CABAZITAXEL | 7 | 0.0020 |
| 5 | POLATUZUMAB VEDOTIN | 20 | 0.0020 |
| 6 | PENTOSTATIN | 2 | 0.0019 |
| 7 | PERMETHRIN | 3 | 0.0017 |
| 8 | BICALUTAMIDE | 24 | 0.0016 |
| 9 | IBRITUMOMAB TIUXETAN | 2 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyrethroid [EPC] | 3 | 0.0017 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 5 | 0.0009 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 3 | Androgen Receptor Inhibitor [EPC] | 33 | 0.0004 |
| 4 | Antiparasitic [EPC] | 2 | 0.0004 |
| 5 | Pediculicide [EPC] | 2 | 0.0004 |
| 6 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 36 | 0.0004 |
| 8 | Topoisomerase Inhibitor [EPC] | 26 | 0.0003 |
| 9 | Bile Acid Sequestrant [EPC] | 4 | 0.0003 |